| A multisociety Delphi consensus statement on new fatty liver disease nomenclature ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ... Hepatology 78 (6), 1966-1986, 2023 | 5734 | 2023 |
| A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement M Eslam, PN Newsome, SK Sarin, QM Anstee, G Targher, ... Journal of hepatology 73 (1), 202-209, 2020 | 5074 | 2020 |
| Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease L Miele, V Valenza, G La Torre, M Montalto, G Cammarota, R Ricci, ... Hepatology 49 (6), 1877-1887, 2009 | 1895 | 2009 |
| A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis SA Harrison, P Bedossa, CD Guy, JM Schattenberg, R Loomba, R Taub, ... New England Journal of Medicine 390 (6), 497-509, 2024 | 1552 | 2024 |
| Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups A Lonardo, S Bellentani, CK Argo, S Ballestri, CD Byrne, SH Caldwell, ... Digestive and Liver Disease 47 (12), 997-1006, 2015 | 563 | 2015 |
| The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota ML Balmer, E Slack, A de Gottardi, MAE Lawson, S Hapfelmeier, L Miele, ... Science translational medicine 6 (237), 237ra66-237ra66, 2014 | 526 | 2014 |
| Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis EA Selvaraj, FE Mózes, ANA Jayaswal, MH Zafarmand, Y Vali, JA Lee, ... Journal of hepatology 75 (4), 770-785, 2021 | 412 | 2021 |
| A phase 2 randomized trial of survodutide in MASH and fibrosis AJ Sanyal, P Bedossa, M Fraessdorf, GW Neff, E Lawitz, E Bugianesi, ... New England Journal of Medicine 391 (4), 311-319, 2024 | 379 | 2024 |
| Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease: A decalogue from the Italian Association for the Study of the Liver (AISF) Expert … P Loria, LE Adinolfi, S Bellentani, E Bugianesi, A Grieco, S Fargion, ... Digestive and liver disease 42 (4), 272-282, 2010 | 375 | 2010 |
| Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores C Bianco, O Jamialahmadi, S Pelusi, G Baselli, P Dongiovanni, I Zanoni, ... Journal of hepatology 74 (4), 775-782, 2021 | 373 | 2021 |
| NAFLD in children: new genes, new diagnostic modalities and new drugs V Nobili, A Alisi, L Valenti, L Miele, AE Feldstein, N Alkhouri Nature reviews Gastroenterology & hepatology 16 (9), 517-530, 2019 | 354 | 2019 |
| Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial C Loguercio, P Andreone, C Brisc, MC Brisc, E Bugianesi, M Chiaramonte, ... Free Radical Biology and Medicine 52 (9), 1658-1665, 2012 | 347 | 2012 |
| Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging … A Grieco, M Pompili, G Caminiti, L Miele, M Covino, B Alfei, GL Rapaccini, ... Gut 54 (3), 411-418, 2005 | 346 | 2005 |
| AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions A Lonardo, F Nascimbeni, G Targher, M Bernardi, F Bonino, E Bugianesi, ... Digestive and Liver Disease 49 (5), 471-483, 2017 | 338 | 2017 |
| Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis L Miele, S Vallone, C Cefalo, G La Torre, C Di Stasi, FM Vecchio, ... Journal of hepatology 51 (4), 778-786, 2009 | 324 | 2009 |
| MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals B Donati, P Dongiovanni, S Romeo, M Meroni, M McCain, L Miele, S Petta, ... Scientific reports 7 (1), 4492, 2017 | 301 | 2017 |
| NASH in lean individuals R Younes, E Bugianesi Seminars in liver disease 39 (01), 086-095, 2019 | 279 | 2019 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 260 | 2022 |
| Pathophysiology of non alcoholic fatty liver disease S Petta, A Gastaldelli, E Rebelos, E Bugianesi, P Messa, L Miele, ... International journal of molecular sciences 17 (12), 2082, 2016 | 252 | 2016 |
| The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease L Miele, G Beale, G Patman, V Nobili, J Leathart, A Grieco, M Abate, ... Gastroenterology 135 (1), 282-291. e1, 2008 | 238 | 2008 |
Antonio GriecoProfessore associato, Università cattolica del sacro cuore, Facoltà di Medicina e Chirurgia A. Gemelli, RomaVerified email at rm.unicatt.it
